drugset / Trial / NCT03174041

A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin

NCT03174041

Phase 1 Completed 63 enrolled Genentech, Inc.
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to assess the potential for a drug interaction between GDC-0853 and midazolam, itraconazole, rosuvastatin, and simvastatin.

Timeline

Start
2017-04-18
Primary completion
2017-06-23
Completion
2017-06-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenebrutinib Small molecule
Subject Itraconazole Small molecule
Subject Midazolam Small molecule
Subject Rosuvastatin Small molecule
Subject Simvastatin Small molecule

Indications

No indication recorded.